Marco Stellato

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Radim Kubeš

University Hospital in Motol

CZECH REPUBLIC

View details

siranoush manoukian

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Pasquale Rescigno

Clin. Snr Lecturer/Honorary Consultant

Newcastle University

UNITED KINGDOM

View details

Jakub Kucharz

Associate Professor

Centrum Onkologii-Instytut im Marii Skłodowskiej-Curie Warszawa

POLAND

View details

Sara Bleve

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

Ondrej Fiala

Charles University

CZECH REPUBLIC

View details

Vincenza Conteduca

Associate Professor

University of Foggia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco Stellato

Research Interests

Explore related searches

Contact this professor

Articles (10)

Pathological Complete Response in Metastatic Renal Cell Carcinoma Patients Treated With Cabozantinib Plus Nivolumab. Case Series and Literature Review.

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2(EV) Study

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients

Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?

Hot topics in genitourinary cancers: A multidisciplinary discussion on state-of-the-art and latest developments among international experts and patient advocacy.

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.

Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).

Collaborators (7)

Radim Kubeš

siranoush manoukian

Pasquale Rescigno

Jakub Kucharz

Sara Bleve

Ondrej Fiala

Vincenza Conteduca

Make your next move.